Savasan Zeynep Alpay, Romero Roberto, Chaiworapongsa Tinnakorn, Kusanovic Juan Pedro, Kim Sun Kwon, Mazaki-Tovi Shali, Vaisbuch Edi, Mittal Pooja, Ogge Giovanna, Madan Ichchha, Dong Zhong, Yeo Lami, Hassan Sonia S
Perinatology Research Branch, NICHD, NIH, DHHS, Detroit, Michigan, USA.
J Matern Fetal Neonatal Med. 2010 Aug;23(8):828-41. doi: 10.3109/14767050903440471.
Vaginal bleeding, placental abruption, and defective placentation are frequently observed in patients with preterm prelabor rupture of membranes (PROM). Recently, a role of vascular endothelial growth factor (VEGF) and its receptor, VEGF receptor (VEGFR)- 1 has been implicated in the mechanisms of membrane rupture. The purpose of this study was to determine whether the soluble form of VEGFR-1 and -2 concentrations in amniotic fluid (AF) change with preterm PROM, intra-amniotic infection/inflammation (IAI), or parturition.
This cross-sectional study included 544 patients in the following groups: (1) midtrimester (MT) (n = 48); (2) preterm labor (PTL) leading to term delivery (n = 143); (3) PTL resulting in preterm delivery with (n = 72) and without IAI (n = 100); (4) preterm PROM with (n = 46) and without IAI (n = 42); (5) term in labor (n = 48); and (6) term not in labor (n = 45). The concentrations of sVEGFR-1 and sVEGFR-2 were determined by ELISA. Non-parametric statistics and logistic regression analysis were applied.
(1) Preterm PROM (with and without IAI) had a lower median AF concentration of sVEGFR-1 than patients with PTL who delivered at term (p < 0.001 for each comparison); (2) A decrease in AFsVEGFR-1 concentrations per each quartile was associated with PROM after adjusting for confounders (OR 1.8; 95%CI 1.4-2.3); (3) IAI, regardless of the membrane status, was not associated with a change in the median AF concentrations of sVEGFR-1 and sVEGFR-2 (p > 0.05 for each comparison); and (4) Spontaneous term and PTL did not change the median sVEGFR-1 and sVEGFR-2 concentrations (p > 0.05 for each comparison).
(1) This is the first evidence that preterm PROM is associated with a lower AF concentration of sVEGFR-1 than patients with PTL intact membranes. These findings cannot be attributed to gestational age, labor, or IAI; and (2) AF concentrations of sVEGFR-2 did not change with preterm PROM, IAI, or labor at term and preterm.
胎膜早破(PROM)早产患者常出现阴道出血、胎盘早剥和胎盘植入异常。最近,血管内皮生长因子(VEGF)及其受体VEGF受体(VEGFR)-1在胎膜破裂机制中的作用受到关注。本研究旨在确定羊水(AF)中可溶性VEGFR-1和-2浓度是否会因早产PROM、羊膜腔内感染/炎症(IAI)或分娩而发生变化。
这项横断面研究纳入了544例患者,分为以下几组:(1)孕中期(MT)(n = 48);(2)足月分娩的早产(PTL)(n = 143);(3)伴有(n = 72)和不伴有IAI(n = 100)的早产PTL;(4)伴有(n = 46)和不伴有IAI(n = 42)的早产PROM;(5)足月临产(n = 48);(6)足月未临产(n = 45)。采用酶联免疫吸附测定法(ELISA)测定可溶性VEGFR-1和sVEGFR-2的浓度。应用非参数统计和逻辑回归分析。
(1)早产PROM(伴有和不伴有IAI)的羊水sVEGFR-1中位浓度低于足月分娩的PTL患者(每次比较p < 0.001);(2)在校正混杂因素后,每降低一个四分位数的羊水sVEGFR-1浓度与PROM相关(比值比1.8;95%置信区间1.4 - 2.3);(3)无论胎膜状态如何,IAI与羊水sVEGFR-1和sVEGFR-2中位浓度的变化均无关(每次比较p > 0.05);(4)足月自然分娩和PTL未改变sVEGFR-1和sVEGFR-2的中位浓度(每次比较p > 0.05)。
(1)这是首个证据表明,与胎膜完整的PTL患者相比,早产PROM患者的羊水sVEGFR-1浓度较低。这些发现不能归因于孕周、分娩或IAI;(2)羊水sVEGFR-2浓度不会因早产PROM、IAI或足月及早产分娩而发生变化。